Performance analysis of Cara Therapeutics (TVRD)
Annual Return
Over the past 3 years, TVRD has had an average annual return of -70.02%, underperforming the benchmark SPY, which returned +19.62% annual.
Over the past 5 years, TVRD has had an average annual return of -63.67%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, TVRD has had an average annual return of -35.17%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Jan 31, 2014, TVRD has had an average annual return of -33.46%, underperforming the benchmark SPY, which returned +14.11% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -33.33% | -76.46% | -31.42% | -93.08% | -11.83% | -19.50% | -6.08% | +23.92% | +6.21% | +31.75% | -44.90% | +69.11% |
| 2014 | |||||||||||
| -22.77% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -8.60% | +1.18% | -20.93% | -0% | +7.35% | -43.84% | +51.22% | -33.33% | |||||
| 2025 | -21.01% | -0.96% | +5.83% | +64.22% | +13.59% | -17.70% | +11.35% | +15.21% | +30.12% | -88.07% | -11.00% | +4.49% | -76.46% |
| 2024 | -23.96% | +50.46% | +6.98% | -17.45% | -13.57% | -60.24% | +35% | +3.33% | -14.34% | +0.42% | -2.08% | +68.09% | -31.42% |
| 2023 | +8.75% | -13.01% | -51.68% | -14.46% | -24.29% | -11.00% | +17.66% | -22.80% | -34.66% | -23.21% | -25.03% | -23.10% | -93.08% |
| 2022 | -4.93% | -10.45% | +17.15% | -28.23% | -4.58% | +9.73% | -4.27% | +18.08% | -9.31% | +0.43% | +25.53% | -8.98% | -11.83% |
| 2021 | +23.59% | -1.87% | +18.31% | -40.35% | +4.94% | +5% | -16.11% | +31.83% | -2.09% | +8.93% | -21.69% | -7.58% | -19.50% |
| 2020 | -0.06% | -6.65% | -12.11% | +12.19% | +7.09% | +7.75% | -3.87% | -5.72% | -17.90% | +4.20% | +10.63% | +3.14% | -6.08% |
| 2019 | +17.31% | +11.80% | +15.08% | -2.76% | +7.76% | +4.57% | +11.35% | -2.09% | -22.01% | +13.57% | +25.14% | -37.99% | +23.92% |
| 2018 | +19.85% | -4.70% | -11.45% | +0% | +26.34% | +22.43% | -6.37% | +12.50% | +18.74% | -21.76% | -2.99% | -28.49% | +6.21% |
| 2017 | +64.91% | +4.63% | +14.72% | -13.60% | +4.22% | -7.06% | -8.77% | +2.07% | -4.47% | -8.40% | -0.71% | -1.69% | +31.75% |
Drawdown analysis of Cara Therapeutics (TVRD)
The maximum drawdown for the TVRD was -99.86%, occurring on Jun 26, 2026. This drawdown has not yet recovered.
The current TVRD drawdown is -99.73%.
Since Jan 31, 2014 TVRD has experienced the following drawdowns:
- 50% or more: 4 times
- 40% or more: 4 times
- 30% or more: 4 times
- 20% or more: 4 times
- 10% or more: 5 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.86% | Apr 9, 2021 | 1309 | Jun 26, 2026 | Ongoing | Ongoing | Ongoing |
| -80.50% | Aug 5, 2015 | 225 | Jun 27, 2016 | 251 | Jun 26, 2017 | 476 |
| -66.16% | Jun 28, 2017 | 684 | Mar 18, 2020 | 264 | Apr 6, 2021 | 948 |
| -65.50% | Mar 5, 2014 | 161 | Oct 22, 2014 | 197 | Aug 5, 2015 | 358 |
| -17.89% | Jan 31, 2014 | 3 | Feb 5, 2014 | 3 | Feb 10, 2014 | 6 |
| -4.33% | Feb 18, 2014 | 1 | Feb 19, 2014 | 1 | Feb 20, 2014 | 2 |
| -3.87% | Feb 10, 2014 | 1 | Feb 11, 2014 | 4 | Feb 18, 2014 | 5 |
| -3.47% | Feb 21, 2014 | 1 | Feb 24, 2014 | 2 | Feb 26, 2014 | 3 |
| -2.28% | Apr 6, 2021 | 1 | Apr 7, 2021 | 1 | Apr 8, 2021 | 2 |